Clinical trial
Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age
NCT00231920 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00231920 |
|---|---|
| Title | Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age |
| Official title | Prospective Pilot Safety Study Administering Two Doses of Inactivated Influenza Vaccine to Infants 10-22 Weeks of Age |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Fluzone |
| Enrollment | 23 |
| Start date | Oct 1, 2004 |
| Primary completion | Aug 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Oct 4, 2005 |
| Last update posted | Aug 12, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: